Clinical Mass Spectrometry Market to Find Better Growth with US$ 697.2 million, to grow at CAGR of 5.5% by 2027
The Global Clinical Mass Spectrometry Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Clinical Mass Spectrometry Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Clinical Mass Spectrometry market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Clinical Mass Spectrometry Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
The increasing investments in R&D activities by pharmaceutical companies are expected to drive growth of the global clinical mass spectrometry market over the forecast period. Moreover, mass spectrometry play a major role in laboratory medicine. For instance, in 2019, Biotage AB entered into a collaboration with Shandong Yingsheng Biotechnology Co., Ltd to focus on research, production, and sales of in vitro diagnostic reagents and medical equipment. This collaboration aims to build a genetic detection platform and mass spectrometry detection platform around metabolomics and genetics.
Moreover, under this collaboration, Biotage and Yingsheng agreed to develop clinical mass spectrometry applications in China, where Biotage will offer systems and consumables from its analytical chemistry portfolio and Yingsheng will sell it with its brand name. Furthermore, adoption of clinical mass spectrometry in laboratory developed tests (LDTs) is expected to drive growth of this market over the forecast period. Technological advancements such as sensitive analytical capabilities and enhancements continue to bring the technology to the edge of new scientific discovery and research applications. Furthermore, matrix-assisted laser desorption/ionization – time of flight (MALDI-TOF) have various applications in microbiology laboratories. MALDI-TOF systems are designated as medical devices that support FDA-cleared or CE-marked assays. In addition, assays that received FDA clearance or CE-marking in the recent past are using MALDI-TOF for microbiological identifications, which is expected to drive growth of the market over the forecast period. These assays are different from the majority of the clinical mass spectrometry market, which is covered by laboratory developed tests (LDTs).
Browse 43 Market Data Tables and 33 Figures spread through 169 Pages and in-depth TOC on “Global Clinical Mass Spectrometry Market, by Product Type (Gas chromatography–mass spectrometry (GC-MS) Instrument, Liquid chromatography–mass spectrometry (LC-MS) Instrument, MALDI-TOF Mass Spectrometer, Capillary electrophoresis–mass spectrometry, and Ion mobility spectrometry-mass spectrometry), by Application (Clinical Testing, Proteomics, and Drug discovery), by End User (Research Laboratories, Diagnostic Laboratories, and Hospitals), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Global Forecast to 2027”
Key Takeaways of the Clinical Mass Spectrometry Market:
The global clinical mass spectrometry market is expected to exhibit a CAGR of 5.5% over the forecast period (2019-2027), owing to technological advancements in mass spectrometry and rising adoption of mass spectrometry in laboratory developed tests.
Among regions, Asia Pacific is expected to witness significant growth in the global clinical mass spectrometry market over the forecast period, owing to high R&D investments by pharmaceutical companies in the region
Among product type, gas chromatography-mass spectrometry (GC-MS) instrument segment held a dominant position in the clinical mass spectrometry market over the forecast period, owing to increasing number of adoption of this technology by players operating in the market
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/193
Reasons to Purchase this Report
• Current and future of global Clinical Mass Spectrometry Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Clinical Mass Spectrometry Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Clinical Mass Spectrometry Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Clinical Mass Spectrometry Industry Impact
Chapter 2 Global Clinical Mass Spectrometry Competition by Types, Applications, and Top Regions and Countries
2.1 Global Clinical Mass Spectrometry (Volume and Value) by Type
2.3 Global Clinical Mass Spectrometry (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Clinical Mass Spectrometry Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Clinical Mass Spectrometry Market Analysis
Chapter 6 East Asia Clinical Mass Spectrometry Market Analysis
Chapter 7 Europe Clinical Mass Spectrometry Market Analysis
Chapter 8 South Asia Clinical Mass Spectrometry Market Analysis
Chapter 9 Southeast Asia Clinical Mass Spectrometry Market Analysis
Chapter 10 Middle East Clinical Mass Spectrometry Market Analysis
Chapter 11 Africa Clinical Mass Spectrometry Market Analysis
Chapter 12 Oceania Clinical Mass Spectrometry Market Analysis
Chapter 13 South America Clinical Mass Spectrometry Market Analysis
Chapter 14 Company Profiles and Key Figures in Clinical Mass Spectrometry Business
Chapter 15 Global Clinical Mass Spectrometry Market Forecast (2021-2027)
Chapter 16 Conclusions
Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/193
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire